Tudor Investment Corp’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-24,464
| Closed | -$58.7K | – | 1574 |
|
2023
Q4 | $58.7K | Buy |
24,464
+2,081
| +9% | +$4.99K | ﹤0.01% | 1390 |
|
2023
Q3 | $76.1K | Buy |
+22,383
| New | +$76.1K | ﹤0.01% | 1401 |
|
2022
Q2 | – | Sell |
-32,557
| Closed | -$1.34M | – | 1665 |
|
2022
Q1 | $1.34M | Buy |
+32,557
| New | +$1.34M | 0.03% | 707 |
|
2021
Q4 | – | Sell |
-35,580
| Closed | -$1.78M | – | 1733 |
|
2021
Q3 | $1.78M | Buy |
35,580
+30,787
| +642% | +$1.54M | 0.03% | 635 |
|
2021
Q2 | $302K | Sell |
4,793
-4,100
| -46% | -$258K | 0.01% | 1263 |
|
2021
Q1 | $826K | Sell |
8,893
-7,756
| -47% | -$720K | 0.02% | 918 |
|
2020
Q4 | $1.49M | Buy |
+16,649
| New | +$1.49M | 0.04% | 533 |
|
2017
Q2 | – | Sell |
-7,000
| Closed | -$203K | – | 1093 |
|
2017
Q1 | $203K | Sell |
7,000
-2,700
| -28% | -$78.3K | 0.01% | 1211 |
|
2016
Q4 | $319K | Buy |
+9,700
| New | +$319K | 0.01% | 967 |
|
2016
Q3 | – | Sell |
-16,200
| Closed | -$456K | – | 1444 |
|
2016
Q2 | $456K | Sell |
16,200
-8,432
| -34% | -$237K | 0.01% | 756 |
|
2016
Q1 | $895K | Sell |
24,632
-2,164
| -8% | -$78.6K | 0.02% | 426 |
|
2015
Q4 | $1.07M | Sell |
26,796
-5,570
| -17% | -$223K | 0.03% | 324 |
|
2015
Q3 | $922K | Buy |
32,366
+17,066
| +112% | +$486K | 0.03% | 371 |
|
2015
Q2 | $504K | Buy |
15,300
+2,608
| +21% | +$85.9K | 0.01% | 738 |
|
2015
Q1 | $365K | Buy |
12,692
+5,192
| +69% | +$149K | 0.01% | 914 |
|
2014
Q4 | $204K | Sell |
7,500
-16,500
| -69% | -$449K | 0.01% | 1250 |
|
2014
Q3 | $511K | Sell |
24,000
-5,400
| -18% | -$115K | 0.02% | 644 |
|
2014
Q2 | $660K | Buy |
29,400
+8,657
| +42% | +$194K | 0.03% | 377 |
|
2014
Q1 | $524K | Buy |
+20,743
| New | +$524K | 0.02% | 481 |
|
2013
Q3 | – | Sell |
-21,900
| Closed | -$316K | – | 830 |
|
2013
Q2 | $316K | Buy |
+21,900
| New | +$316K | 0.02% | 521 |
|